Does total volume of physical activity matter more than pattern for onset of CVD? A prospective cohort study of older British men. by Jefferis, BJ et al.
International Journal of Cardiology 278 (2019) 267–272
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdDoes total volume of physical activity matter more than pattern for onset
of CVD? A prospective cohort study of older British menBarbara J. Jefferis a,⁎, Tessa J. Parsons a, Claudio Sartini a, Sarah Ash a, Lucy T. Lennon a, Olia Papacosta a,
Richard W. Morris b, S. Goya Wannamethee a, I-Min Lee c, Peter H. Whincup d
a Department of Primary Care & Population Health, University College London, Rowland Hill Street, London, NW3 2PF, UK
b Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK
c Harvard Medical School, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA02215, USA
d Population Health Research Institute, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK⁎ Corresponding author.
E-mail address: b.jefferis@ucl.ac.uk (B.J. Jefferis).
https://doi.org/10.1016/j.ijcard.2018.12.024
0167-5273/© 2018 The Authors. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oArticle history:
Received 20 September 2018
Received in revised form 29 November 2018
Accepted 6 December 2018
Available online 13 December 2018Aims:With increasing age, physical inactivity and sedentary behaviour levels increase, as does cardiovascular dis-
ease (CVD) incidence. We investigate how device-measured sedentary behaviour and physical activity (PA) are
related to CVD onset in men aged 70+; whether the total volume of activity is more important than pattern.
Methods and results: Prospective population-based cohort study ofmen recruited from24UKGeneral Practices in
1978–80. In 2010–12, 3137 survivors were invited to complete questionnaires and wear an Actigraph GT3x ac-
celerometer for 7 days. PA intensity was categorised as sedentary, light and moderate to vigorous (MVPA). Men
were followed up forMyocardial Infarction, stroke and heart failure (ICD9 410–414, 430–438 and 428)morbidity
andmortality from 2010 to 12 to June 2016. Hazard Ratios (HRs) for incident Cardiovascular Disease (CVD)were
estimated. 1528/3137 (49%) men had sufﬁcient accelerometer data. 254 men with pre-existing CVD were
excluded. Participants' mean age was 78.4 (range 71–92) years. After median 4.9 years follow-up, 122 ﬁrst
CVD events occurred in 1181 men (22.7/1000 person-years) with complete data. For each additional 30 min in
sedentary behaviour, light PA,10 min in MVPA, or 1000 steps/day, HRs for CVD were 1.09(95%CI 1.00, 1.19),
0.94(0.85, 1.04), 0.88(0.81, 0.96) and 0.86(0.78 to 0.95) respectively, adjusted for measurement-related
factors, socio-demographics, health behaviours and disability. HRs for accumulating 150 min/week MVPA in
bouts ≥1 min and bouts ≥10 min were 0.47(0.32 to 0.69), and 0.49(0.25, 0.98).
Conclusions: In older men, high volume of steps or MVPA rather than MVPA bouts was associated with reduced
CVD risk.. This is an open© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Heart failure1. Introduction
Physical activity (PA) is a key preventivemeasure against cardiovas-
cular disease (CVD): with 25–30% reductions in risk of CVD events in
middle aged adults doing moderate compared to low PA [1]. However
most evidence underpinning PA guidelines is derived from epidemio-
logic studies linking self-reported activity data to onset of CVD events
and mortality [2].
Current guidelines [2,3] suggest accumulatingmoderate to vigorous
physical activity (MVPA) in 10min bouts, based on trial data for cardio-
metabolic risk factors only, not clinical end points [2]. However it is not
clear whether the total volume of activity is critical for prevention of
CVD events, or if 10 min bouts are necessary. Studies using self-
reported PA are not well placed to answer this question. However the
availability of body-worn sensors in large scale epidemiologic studiesaccess article underenables measurement of the pattern of accumulation of activities and
the number of minutes per day spent in different intensities of activity.
Importantly, this includes light activity (the most common intensity),
which can be hard to recall.
Many studies report that higher levels of self-reported sedentary
time are associated with CVD onset [4], although self-report sedentary
behaviours are prone to measurement error or recall bias [5,6]. Experi-
mental studies suggest beneﬁts of breaking up sedentary time to im-
prove levels of metabolic and hemostatic markers [7,8]. Hence activity
guidelines now suggest avoiding “long” sedentary periods [3]. However
it is unclear howmuch sedentary behaviour and in what patterns, is as-
sociated with onset of CVD events.
To date, no published studies with device-measured PA and seden-
tary behaviour data have investigated how PA is related to incident
fatal and non-fatal CVD events. Using a cohort of older British men, we
investigated (i) how device-measured PA and sedentary behaviour
were related to incident CVD; (ii) the strength and shape of dose-
response associations, to better understand whether the reductions inthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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level atwhich the beneﬁts per unit of activity decrease; (iii)whether the
association of sedentary behaviourwith CVD risk depended on PA level;
and (iv) associations between patterns of accumulation of activity
(including bout length, and sedentary breaks) and CVD. Older adults
are an understudied population yet they are important because they
are growing rapidly and the burden of CVD increases with age, whilst
PA levels decline rapidly.
2. Methods
2.1. Study population
The British Regional Heart Study (BRHS) is a prospective cohort study of 7735 men
recruited from a single General Practice in each of 24 British towns in 1978–80 (age 40–
59 years). In 2010–2012, survivors (n = 3137) were invited to a physical re-
examination including objective PA assessment [9]. The National Research Ethics Service
Committee London provided ethical approval, men provided informed written consent
in accordance with the Declaration of Helsinki.
2.2. Measurements at 2010–2012 examination
2.2.1. Objective physical activity assessment
Menwere invited to wear a GT3x accelerometer (Actigraph, Pensacola, FL. USA) over
the right hip for 7 days, during waking hours, except for bathing and swimming (2% re-
ported swimming). Accelerometer data was processed using standard methods [10] and
non-wear time was excluded using the R package “Physical Activity” [10,11]. Participants
with ≥600 minwear time, on ≥3 days were included, a conventional requirement for esti-
mating usual PA level [10,12–14]. Each minute of wear time was categorised using inten-
sity threshold values of counts per minute (CPM) from the vertical axis developed for
older adults: b100 for sedentary behaviour (b1.5 MET), 100–1040 for light activity
(LIPA) (1.5–3 MET) and N1040 for MVPA, (≥3 MET) [15].
2.2.2. Nurse measured CVD risk factors
Nurses took fasting blood samples; lowdensity lipoprotein cholesterol (LDLC)was ad-
justed for duration of fasting and time of day. Systolic blood pressure wasmeasured twice
(Omron recorder, mm Hg) and the average of 2 readings used, adjusted for cuff size.
The Chronic Kidney Disease Epidemiology Collaboration Creatinine-Cystatin (CKD-EPI
cr-cys) equation was used to calculate estimated Glomerular Filtration Rate (eGFR) [16].
Chronic Kidney Disease was deﬁned as eGFRb45 ml/min per 1.73 m2 [16]. BMI, (kg/m2)
was calculated from measured height (Harpenden stadiometer) and weight (Tanita
body composition analyser (BC-418-MA)) in light indoor clothing.
2.2.3. Questionnaire data
Men self-reported current cigarette smoking, alcohol consumption, usual night-time
sleep duration, living alone or with others, and doctor diagnosis of type 2 diabetes, atrial
ﬁbrillation, pre-existing CVD (heart attack, heart failure or stroke (with symptoms lasting
N24 h)), and use of medications including antihypertensives (British National Formulary
(BNF) codes 2.2.1, 2.2.8, 2.4, 2.5.5 and 2.6.2) or statins (BNF 2.12). Mobility disability
was present if participants were unable to do any of (i) walk 200 yards without stopping
and without discomfort (ii) climb a ﬂight of 12 stairs without holding on and taking a rest
or (iii) benddown and pick up a shoe from theﬂoor. Social classwas based on longest held
occupation at study entry (1978–80) (categorised as manual and non-manual). Region of
residence (1978–80) was grouped into Scotland, North, Midlands and South of England.
2.2.4. CVD events and mortality
Allmenwere followedup for all-causemortality andﬁrst fatal or non-fatalMyocardial
Infarction, stroke or heart failure event (herein referred to as CVD), occurring between the
2010–2012 survey and 1st June 2016. All deaths were ascertained through the National
Health Services Central Registers. Deaths were identiﬁed from International Classiﬁcation
of Disease (ICD) 9 codes: MI 410–414 (ICD 10 codes I20–I25), Stroke 430–438, (ICD10
I60–69) and Heart Failure 428 (ICD10 I50). Nonfatal events were recorded from yearly re-
views of primary care notes (which include correspondence and diagnoses from second-
ary care). MI was reported as heart attack or coronary thrombosis, diagnosed in
accordance with WHO criteria [17] and stroke events were those that produced a neuro-
logical deﬁcit present for N24 h. Physician diagnosis of Heart failure was veriﬁed using
available clinical information (including symptoms, signs, investigations, and treatment
response) consistent with current diagnostic practice [18]; cases with a strong likelihood
of alternative diagnoses were excluded. All cases were adjudicated by study director
(PHW).
2.3. Statistical methods
Means, medians or proportions of covariates selected a priori were compared among
quartiles of MVPA. Hazard Ratios (HRs) for CVD according to (i) total steps per day and
total daily minutes in (ii) MVPA (iii) LIPA and (iv) sedentary behaviour were estimated
using Cox Proportional Hazards models. Each activity measure was analysed in quartiles
and then as a continuous variable. To facilitate interpretation, HRs were estimated foreach increase of 1000 steps/day, 30 min of sedentary behaviour or LIPA and 10 min of
MVPA. Survival timeswere censored at death (any cause) or 1 June 2016.Modelswere cu-
mulatively adjusted as follows: Model 1 included age, region of residence, average accel-
erometer wear time (minutes/day), season of wear (May–September vs October–April).
Model 2; additionally: social class, living alone, sleep duration, smoking status, alcohol
consumption and BMI.Model 3; additionally: presence of mobility disability. Model 4; ad-
ditionally: another intensity of PA to investigate whether (i) MVPA and sedentary behav-
iour and (ii) MVPA and LIPA were associated with CVD independently of each other. We
compared model ﬁt between linear and quadratic models (using a likelihood ratio test),
to test the shape of association between activity and CVD based on a priori expectations
about the shape of association [19]. The shapes of associations were checked using
penalised splines (a non-parametric estimation method which makes few assumptions
about the underlying shape of the association). Predicted values from spline models
were plotted. To assessmodelﬁt, the Akaike information criterion (AIC)was comparedbe-
tween linear and spline models.
We estimated the HR for CVD for men who accumulated ≥150 min MVPA/week
(vs b150 min) in bouts lasting (i) ≥1 and (ii) ≥10 consecutive minutes (current recom-
mendation [3]. Next we estimated the HR for CVD per minute of MVPA in bouts lasting
(i) 1–9 min and (ii) ≥10 min, and tested the difference between the two coefﬁcients.
Models were repeated for light PA. For sedentary behaviour we compared bouts lasting
1–15 min, 16–30, 31–60 and over 60 min. We estimated the HR for CVD for the number
of sedentary breaks/hour, (deﬁned as the interruption of a sedentary bout lasting
N1 min by ≥1 min of LIPA or MVPA). Number of sedentary breaks per hour was analysed
in quartiles and models were adjusted for total sedentary time.
Sensitivity analyses (seeWebAppendix), investigated (i) the non-normal distribution
ofMVPA, (ii) the percentage of theday spent in each activity (iii) excluding theﬁrst year of
follow-up and (iv) excluding the ﬁrst year of follow-up and men with disability
(v) confounding by socio-economic status (vi) confounding by other co-morbidities
(vii) additional adjustments for lipids, blood pressure and lipid and blood pressure lower-
ing medications. The impact of missing co-variate data was investigated by usingmultiple
imputation in v, vi and vii. Interactions were investigated between sedentary behaviour
and PA level, and secondly between each of MVPA, LIPA and sedentary behaviour and
age and adiposity.
3. Results
Of 3137 surviving men, 1566 (50%) agreed to participate and
returned an accelerometer with data. A comparison of included and ex-
cludedparticipants characteristics reported 10 years previously is in Sup-
plementary Table 1: men with Actigraph data tended to be younger,
fromnon-manual social class,more active, weighed less butwere of sim-
ilar height to men without Actigraph data. Of the 1566 men with
Actigraph data, 1528 (49%) had ≥600 min/day wear time on ≥3 days.
254 men with pre-existing heart attack, heart failure or stroke were ex-
cluded. Of the remaining 1274, participants' mean age was 78.4 (range
71–92) years. Mean accelerometer wear time was 855 min/day, of
which 616 min were in sedentary behaviour and 199 in LIPA and 40 in
MVPA. The distribution of MVPA minutes was right-skewed. The distri-
bution of bouts spent in each intensity of activity is in Supplementary
Table 2.
There were dose-response associations across quartiles of total
MVPA; men who were more active compared to less active were youn-
ger, less likely to smoke cigarettes, and had greater alcohol consump-
tion, lower mean BMI, prevalence of mobility disability, CKD, diabetes,
atrial ﬁbrillation, and use of lipid-and BP lowering medications and
spent less time in sedentary behaviour (Supplementary Table 3). Oppo-
site dose-response associations were observed for sedentary behaviour
quartiles (data not presented).
3.1. PA, sedentary behaviour and CVD events
During a median follow-up of 4.9 years (range 0.1–6.1), 122 CHD,
stroke or heart failure events occurred (80 non-fatal), (22.6/1000 per-
son-years) among 1181 men with complete case data. The risk of CVD
events was lower in the higher quartiles of steps (Table 1) and MVPA
(Table 4) and higher in the lowest quartile of sedentary time
(Table 2). There were no clear dose-response associations across quar-
tiles of light PA (Table 3). We did not ﬁnd statistical evidence for better
ﬁt for quadratic than linear models for any of the PA measures in
relation to CVD events, nor did splines support non-linear associations
(see Web Appendix 1, Figs. 1–4 and Table 4). For each additional
Table 1
Association Between Steps per Day With CVD events, (n=1181 Men).
Quartile 1 (121–2943) Quartile 2
(2944–4540)
Quartile 3
(4541–6406)
Quartile 4
(6407–17,781)
All men, per 1000
stepsd
N Participants (n CVD events) 296 (53) 295 (35) 295(20) 295 (14) 1181 (122)
Person years 1214 1342 1398 1425 5378
CVD events/ 1000 person years 43.6 26.1 14.3 9.8 22.6
HR 95%CI HR 95%CI HR 95%CI HR 95%CI
Model 1a Reference 0.65 (0.41,1.01) 0.36 (0.21,0.63) 0.27 (0.14,0.52) 0.83 (0.75,0.91)
Model 2b Reference 0.67 (0.43,1.06) 0.39 (0.23,0.68) 0.3 (0.15,0.59) 0.84 (0.76,0.93)
Model 3c Reference 0.75 (0.47,1.20) 0.44 (0.25,0.77) 0.34 (0.17,0.67) 0.86 (0.78,0.95)
Bold text indicates pb0.05.
a model 1 = age + region of residence + season of wear + accelerometer wear time.
b model 2 = model 1 + social class + alcohol use + smoking + sleep time + living alone + BMI.
c model 3 = model 2 + mobility disability.
d HR for mortality per 1000 steps per day (continuous variable).
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(Model 1, Table 1). For each additional 30 min in sedentary behaviour
and LIPA or 10 min in MVPA, HRs (Model 1) were 1.14 (1.06, 1.24)
(Table 2), 0.89 (0.80, 0.98) (Table 3) and 0.85 (0.79, 0.93) (Table 4) re-
spectively. Adjustments for socio-demographic factors, health behav-
iours and sleep time (Model 2) and mobility disability (Model 3) did
not appreciably affect estimates and CIs for steps and MVPA but
completely attenuated the association for light PA. In Model 4 adjust-
ment for MVPA and sedentary time (Model 4), the coefﬁcient for sed-
entary time was fully attenuated (Table 2) whereas the MVPA
coefﬁcient was little changed (Table 4).
3.2. Bouts of activity and CVD events
The HR in Model 1 for accumulating ≥150 min MVPA/week
accumulated in sporadic minutes (achieved by 66% of men) compared
to b150min,was 0.47 (0.32 to 0.69), and0.49(0.25, 0.98) for accumulat-
ing 150 min MVPA/week all in bouts lasting ≥10 min (achieved by 16%
of men). Estimates for 1 min bouts were not meaningfully changed in
models 2 or 3, but were attenuated for 10 min bouts in models 2 and
3 (Supplementary Table 5).
The HRs for CVD for each minute of MVPA spent in bouts lasting
1–9 min did not differ from the HR for each minute of MVPA spent in
bouts lasting ≥10 min (p=0.75), nor for LIPA (p= 0.44) (Supplemen-
tary Table 6). The number of minutes spent in sedentary bouts lasting
1–15 min, 16–30, 31–60 and N61 min were all similarly associated
with CVD (Supplementary Table 6). TheHR for CVDdid not differ signif-
icantly between quartiles of sedentary breaks per hour (Supplementary
Table 7). Web Appendix 1 presents sensitivity analyses (relating to the
distribution of MVPA, further exclusions and confounding by SES, addi-
tional co-morbidities and adjustments for variables on the pathwayTable 2
Association Between Minutes per Day in Sedentary Behaviour With CVD events, (n=1181 Me
Quartile 1 (295–560) Quartile 2 (561–615)
N Participants (n CVD events) 296 (24) 295 (23)
Person years 1417 1381
CVD events/ 1000 person years 17.1 16.7
HR 95%CI
Model 1a Reference 0.98 (0.55,1.74)
Model 2b Reference 0.92 (0.52,1.65)
Model 3c Reference 0.90 (0.50,1.60)
Model 4d Reference 0.70 (0.38,1.28)
Bold text indicates pb0.05.
a model 1 = age + region of residence + season of wear + accelerometer wear time.
b model 2 = model 1 + social class + alcohol use + smoking + sleep time + living alone
c model 3 = model 2 + mobility disability.
d model 4 = model 3 + MVPA.
e HR for mortality per 30 minutes of sedentary behaviour per day (continuous variable).between PA and CVD, as well as missing data imputation); these did
not change ourmain conclusions, except that inmodel 4 the association
between MVPA and CVD was attenuated by adjustment for sedentary
time. Interactions were not observed between physical activity level,
age, adiposity and disability (Web Appendix 1).4. Discussion
Consistent prospective associations between higher total daily step
count and minutes spent in MVPA and lower risk of CVD events were
observed in community-dwelling oldermen. Associations changed little
after adjustment for other health behaviours, BMI, and presence of mo-
bility disability. After full adjustment the associations between quartiles
ofMVPA and CVD remained consistently strong, with for example a 72%
reduction in risk of CVD events for men doing 33–56 min/day MVPA
compared to ≤15 min/day. Investigating the shape of associations be-
tween total minutes/day spent in MVPA and steps/day with CVD indi-
cated that the lower CVD risks were gained across the spectrum of
step counts and time in MVPA, not conﬁned to a threshold duration.
Further, the total volume rather than pattern of accrual of physical activ-
ity was the most important inﬂuence on CVD risk.
Our data extends evidence about device measured physical activity
and CVD to include non-fatal as well as fatal CHD, stroke and heart fail-
ure events, other studies only investigated CVD mortality or deﬁned
CVDmore broadly [20–23].Weprovide evidence on anolder population
(72–91 years at baseline), important given the sparsity of data on men
over 80 [21,22], and on a non-US population (all other reports of CVD
[20–23] and all-cause mortality are restricted to USA data [22–30],
and nearly all use one data source). Prior studies did not report tests
of non-linearity in associations between device-measured activity andn).
Quartile 3 (616–671) Quartile 4
(672–1054)
All men, per 30 mine
296 (33) 294 (42) 1181 (122)
1341 1249 5378
24.6 33.6 22.6
HR 95%CI HR 95%CI HR 95%CI
1.42 (0.82,2.47) 2.18 (1.24,3.83) 1.14 (1.06,1.24)
1.32 (0.76,2.31) 1.87 (1.03,3.38) 1.12 (1.03,1.21)
1.20 (0.68,2.10) 1.63 (0.90,2.97) 1.09 (1.00,1.19)
0.81 (0.43,1.52) 0.94 (0.45,1.94) 1.01 (0.90,1.13)
+ BMI.
Table 3
Association Between Minutes per Day in Light Physical Activity With CVD events, (n=1181 Men).
Quartile 1 (5–157) Quartile 2 (158–197) Quartile 3 (198–238) Quartile 4 (239–472) All men, per 30
minutese
N Participants (n CVD events) 296 (45) 295 (34) 296 (19) 294 (24) 1181 (122)
Person years 1233 1318 1428 1400 5378
CVD events/ 1000 person years 36.5 25.8 13.3 17.1 22.6
HR 95%CI HR 95%CI HR 95%CI HR 95%CI
Model 1a Reference 0.75 (0.47,1.19) 0.41 (0.23,0.72) 0.58 (0.33,1.02) 0.89 (0.80,0.98)
Model 2b Reference 0.78 (0.49,1.24) 0.45 (0.26,0.80) 0.67 (0.38,1.20) 0.92 (0.83,1.02)
Model 3c Reference 0.86 (0.53,1.38) 0.49 (0.28,0.87) 0.74 (0.41,1.34) 0.94 (0.85,1.04)
Model 4d Reference 0.93 (0.57,1.50) 0.59 (0.33,1.06) 0.97 (0.53,1.80) 0.99 (0.89,1.11)
Bold text indicates pb0.05.
a model 1 = age + region of residence + season of wear + accelerometer wear time.
b model 2 = model 1 + social class + alcohol use + smoking + sleep time + living alone + BMI.
c model 3 = model 2 + mobility disability.
d model 4 = model 3 + MVPA.
e HR for mortality per 30 minutes of LIPA per day (continuous variable).
270 B.J. Jefferis et al. / International Journal of Cardiology 278 (2019) 267–272CVD mortality, nor speciﬁc bouts of LIPA, and breaks in sedentary time
and only one investigated bouts of SB and MVPA [23].
4.1. PA intensity and duration
Comparing results to other studies using objective PA data is difﬁcult
because deﬁnitions of activity intensity and analysis methods vary. We
found each increase of 1000 steps/daywas associatedwith a 14% reduc-
tion in CVD risk, but other studies have not reported comparable data.
Further, each 10 min/day increase in MVPA was associated with an
11% reduction in CVD risk (approximately 85% reduction per hour of
MVPA), whichwas not explained by adjustment for behavioural and so-
cial confounders and mobility disability. Whilst Evenson et al. using
NHANES data report that CVD mortality was lower in the highest
three quartiles of moderate PA and of MVPA than the lowest quartile,
there did not appear to be a dose-response association, but MVPA was
deﬁned using a higher cut-point (N2020 CPM) in their younger popula-
tion [23].
We did not ﬁnd associations between LIPA and CVD risk, nor did
Evenson's NHANES study [23], although in a different analysis of
NHANES data Schmid et al. found that replacing sedentary time with
LIPA was associated with lower CVD mortality [20]. Another study of
older men [22] found less consistent associations between LIPA and
lower CVD mortality. Whereas, a study of older women reported that
LIPA was associated with lower CVD mortality, even after adjustment
for health and social confounders [21]. In the latter two studies, the
cut-points deﬁning LIPA are not directly comparable to ours.
We found that adjustment for MVPA fully explained the association
betweenhigher sedentary time and raised CVD risk.We did notﬁnd sig-
niﬁcant associations of sedentary breakswith CVD events. Other studiesTable 4
Association Between Moderate to Vigorous Physical Activity (MVPA) With CVD events, (n=11
Quartile 1 (0.4–15) Quartile 2 (16–32)
N Participants (n CVD events) 297 (57) 296 (33)
Person years 1222 1348
CVD events/ 1000 person years 46.7 24.5
HR 95%CI
Model 1a Reference 0.56 (0.36,0.87)
Model 2b Reference 0.58 (0.37,0.91)
Model 3c Reference 0.63 (0.39,1.01)
Model 4d Reference 0.62 (0.38,1.00)
Bold text indicates pb0.05.
a model 1 = age + region of residence + season of wear + accelerometer wear time.
b model 2 = model 1 + social class + alcohol use + smoking + sleep time + living alone
c model 3 = model 2 + mobility disability.
d model 4 = model 3 + sedentary behaviour.
e HR for mortality per 10 minutes of MVPA per day (continuous variable).[22,23] did not ﬁnd consistent associations betweenminutes/day spent
in SB and CVD mortality, but Evenson's study did ﬁnd that more time
spent in longer SB bouts was associated with increased CVD mortality
[23], albeit in a slightly younger population. Although self-reported sed-
entary time (often television viewing time) is associated with CVD risk
[4], reasons for contrasting results may include the difference in objec-
tive vs self-report measures [31], confounders related to TV viewing,
aswell as the older age group studied here (the strength of other classic
risk factors for CVD declines at older ages [32]).
4.2. Linearity of associations
Our results suggest that more daily steps and minutes of MVPA are
beneﬁcial, rather than beneﬁts only accruing above a particular thresh-
old. Whilst setting activity targets may be useful as a behavioural
change tool, at least for CVD, we don't have a clear evidence base for a
target. Nevertheless, accumulating more than around 30 min total
MVPA (not necessarily in 10min bouts), or 4500 steps per day were as-
sociated with lower CVD risks than the lowest quartiles of those mea-
sures. Although other studies report results for tertiles or quartiles
rather than speciﬁcally testing for non-linear continuous associations,
NHANES results suggested linear dose-response only for the average
CPM rather than for MVPA or LIPA [23].
4.3. Pattern of activity: bouts and breaks
Many PA guidelines advise accumulating MVPA in bouts lasting
≥10 min and avoiding long sedentary bouts [2,3]. We did not ﬁnd
clear evidence that sedentary breaks were associated with mortality
risk after accounting for total sedentary time. Overall our results81 Men).
Quartile 3 (33–56) Quartile 4 (57–187) All men, per 10
minutese
294 (15) 294 (17) 1181 (122)
1395 1414 5378
6.5 7.5 22.6
HR 95%CI HR 95%CI HR 95%CI
0.26 (0.14,0.46) 0.31 (0.17,0.55) 0.85 (0.79,0.93)
0.27 (0.15,0.49) 0.34 (0.18,0.62) 0.87 (0.80,0.95)
0.29 (0.16,0.55) 0.37 (0.20,0.68) 0.88 (0.81,0.96)
0.28 (0.14,0.55) 0.34 (0.16,0.74) 0.89 (0.80,0.99)
+ BMI.
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bouts was important. The only other study to investigate bouts in rela-
tion to CVD risk reported some suggestive evidence that more time
spent inMVPA bouts ≥10minwas associatedwith lower CVDmortality,
but the association was non-linear and their bout deﬁnition less strict
(allowing ≤5 min of lower intensity activity within bouts [23]). Hence
for CVD prevention among older men, accumulating ≥10 min bouts of
activity may not be essential; it may be better for older adults to focus
on increasing time spent in moderate (or more intense) activity.
The varied ﬁndings of studies to date indicate that that more studies
are needed; inconsistencies may be due to differences in (i) population
characteristics; e.g., PA levels may vary systematically (ii) age-groups
(iii) devices to measure PA (iv) deﬁnitions of PA intensities (cutpoints)
(v) deﬁnitions of CVD endpoints.
4.4. Interactions of physical activity with other variables
We did not ﬁnd evidence for interactions between SB and MVPA in
relation to CVD risk, as reported for all-cause mortality [33]. Nor did
we ﬁnd that the association between PA or sedentary behaviour and
CVD onset varied by age, BMI or disability status.
4.5. Strengths and limitations
This study beneﬁts from prospectively collected data on exposures,
confounders, mediators and veriﬁed CVD events. Whilst we had a lim-
ited number of events (122 over 5 years among 1181 men), estimates
and CIs did not differ much from models 1(fewer adjustments) to
model 4, nor in sensitivity analyses where missing covariates were im-
puted and 137 events among 1274 men were analysed. The number of
events and low number of MVPA 10 min bouts may have limited our
statistical power when analysing bouts of MVPA. Whilst CHD, stroke
and HF are three different types of CVD, composite end points are com-
monly used in the study of PA and CVD onset; furthermore a recent
meta-analysis did not suggest that the relationships between self-
reported physical activity and incidence of each CVD type differed
[34]. We used Actigraph accelerometers to measure PA; each device
was calibrated by themanufacturer prior to use in the survey. Validation
data for Actigraph accelerometers is available from laboratory and ﬁeld
settings [15,35]. We used the conventional requirement of N3 days ac-
celerometer wear time to estimate habitual PA levels, although 80% of
participants had ≥7 days wear time. We used age-appropriate and vali-
dated cut-points to deﬁne activity intensities [15]; our lower deﬁnition
of MVPA wasmore achievable in older adults. Our sedentary timemea-
sure may include some standing time, but the same deﬁnition per-
formed well compared to Activpal (with postural data) in older adults
[36]. The BRHS study sample was drawn from all parts of Great Britain
and was nationally representative at the point of selection. 28% of all
deaths were due to CVD in the BRHS over the 2010–2016 follow-up pe-
riod, which is the same as the proportion in the UK male population
aged 75–84 years in 2014, suggesting that the BRHS data are represen-
tative of older adults in the UK of a similar age [37]. The response rate to
the accelerometer studywas similar or superior to other studies of older
adults [14,38], nevertheless, study participants were younger and may
have beenmore active than the general population. However even if in-
cluded participants were more active than excluded, as the sample
retained a wide range of PA and sedentary behaviour levels, the
association between PA and CVD should not be biased. Participants
were community-dwelling older white British men, so results may
not apply to women, other ethnicities or youngermen, however associ-
ations between PA or sedentary behaviour and all-cause mortality did
not differ by gender [24,29,30,39,40]. Results did not meaningfully
change in sensitivity analyses excluding men with mobility disability,
and other co-morbidities (type 2 diabetes, chronic kidney disease and
atrial ﬁbrillation), suggesting ﬁndings are not likely due to reverse
causality.5. Conclusions
Whilst previous work found light PA was associated with lower risk
of all-causemortality in oldermen [41], for CVD events, total time spent
in MVPA and total steps emerged as key; accumulating activity was im-
portant, but whether it was sporadic or 10 min bouts did not matter.
This suggests that among older men, it would be beneﬁcial to promote
doingmore activities of an equal or greater intensity than briskwalking
for protection from CVD events, rather than focusing on accumulating
activity in 10 min bouts.
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